The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat. (Q44414285)

2 December 2017

title

The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat. (English)

1 reference

2 December 2017

1 reference

ChEBI release 2020-05-28

Hongbo Zhu

1

1 reference

2 December 2017

Shirzad Jenab

series ordinal

2

1 reference

2 December 2017

Kathy L Jones

series ordinal

3

1 reference

2 December 2017

Charles E Inturrisi

series ordinal

4

1 reference

2 December 2017

language of work or name

1 reference

1 May 2003

1 reference

2 December 2017

number of pages

5

1 reference

Developmental Brain Research

inferred from page(s)

published in

1 reference

2 December 2017

volume

142

1 reference

2 December 2017

issue

2

1 reference

2 December 2017

page(s)

209-213

1 reference

Dextromethorphan. An overview of safety issues

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Opiate withdrawal with dextromethorphan

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

A simple technique for the permanent marking of newborn albino rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Attenuation of acute morphine withdrawal in the neonatal rat by the competitive NMDA receptor antagonist LY235959.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Neonatal type of nonketotic hyperglycinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Molecular and cellular basis of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

The use of opioids in neonates. A retrospective study of 933 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

NMDA antagonists and clonidine block c-fos expression during morphine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Opioid tolerance in neonates: a state-of-the-art review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Characterization of neonatal rat morphine tolerance and dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Inhibition of morphine withdrawal by the NMDA receptor antagonist MK-801 in rat is age-dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Opiate withdrawal during development: are NMDA receptors indispensable?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Time course of enkephalin mRNA and peptides in cultured rat adrenal medulla

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

Ontogeny of morphine withdrawal in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-3806%2803%2900059-2

7 January 2021

10.1016/S0165-3806(03)00059-2

Identifiers

DOI

1 reference

2 December 2017

1 reference